Search
Now showing items 21-26 of 26
Bioymifi suppresses Burkitt’s lymphoma cell line proliferation via cell cycle arrest and apoptosis
(Tropical Journal of Pharmaceutical Research, 2022 Ekim)
Purpose: To find a new treatment alternative for Burkitt’s lymphoma, one of the B cell-derived non Hodgkin's lymphomas that has an extremely aggressive growth profile with a high mortality rate.
Methods: Bioymifi (death ...
Investigation of the relationship between inflammatory blood parameters and seborrheic dermatitis
(2022)
Objective: Seborrheic dermatitis (SD) is a chronic inflammatory disease. The etiology of the disease is still unknown. The systemic immune-inflammation index (SII), red cell distribution width (RDW), mean platelet volume ...
Determination of Ongoing Symptoms, Quality of Life Levels, and Risk Factors in Post-COVID-19 Patients
(MART 2022)
Objective: Studies have reported that most post-COVID-19 patients experience post-disease symptoms, but the results of
these studies have not been interpreted correctly. The present study aimed to determine the ongoing ...
Validation of low-density lipoprotein cholesterol equations in pediatric population
(2023)
Several studies have shown a high prevalence of dyslipidemia in children. Since childhood lipid concentrations continue into adulthood, recognition of lipid abnormalities in the early period is crucial to prevent the ...
Troponin-T value as a prognostic marker in neonates diagnosed with neonatal encephalopathy and receiving hypothermia treatment
(2023)
Abstract. – OBJECTIVE: The aim of this
study was to investigate the effect of Tropo nin-T levels on the prognosis of neonatal en cephalopathy (NE).
PATIENTS AND METHODS: The study in cluded one hundred and eleven ...
Sleep quality and glycemic control in children and adolescents with type 1 diabetes mellitus
(2023)
Abstract. – OBJECTIVE: This study aimed
to investigate the frequency of sleep disorders,
and the relationship between glycemic control
and sleep characteristics in diabetic children
and adolescents.
PATIENTS AND ...